SURGERY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=970865, encodeId=01749e0865a0, content=审稿速度:3.0 经验分享：2021/02/23投稿，2021/05/07接受，一个月左右收到校样。同其他前辈分享的经验差不多，一审一个月左右，二审十几天。审稿人很认真负责，给了很多非常有价值的建议~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47db5408758, createdName=ms2000001912590380, createdTime=Fri Jun 04 13:12:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563308, encodeId=a889563308ff, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：两个审稿人，一个认为文章很好，小修，一个认为语言读不懂，还说懒得读下去，提了一些乱七八糟的问题，拒稿。编辑最终给了大修，现在我很惆怅啊，A revision will require extensive changes and possibly a significant reworking of the manuscript. Please note that we do not guarantee acceptance even after revision. 发篇文章真的伤筋动骨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sat Nov 17 16:59:00 CST 2018, time=2018-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184414, encodeId=fc561184414a8, content=这个杂志是所有的作者都是共一吗，每个作者都要确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3edd5463800, createdName=爱吃萝卜不吃青菜, createdTime=Fri Jan 14 23:03:48 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062690, encodeId=82f810626908a, content=快两个月了还是under review，，，，，是不是凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92645440603, createdName=mnr, createdTime=Thu Oct 21 20:27:07 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096899, encodeId=abc01096899bb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096900, encodeId=091b10969004d, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-06-04 ms2000001912590380

审稿速度:3.0
经验分享：2021/02/23投稿，2021/05/07接受，一个月左右收到校样。同其他前辈分享的经验差不多，一审一个月左右，二审十几天。审稿人很认真负责，给了很多非常有价值的建议~

71 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=970865, encodeId=01749e0865a0, content=审稿速度:3.0 经验分享：2021/02/23投稿，2021/05/07接受，一个月左右收到校样。同其他前辈分享的经验差不多，一审一个月左右，二审十几天。审稿人很认真负责，给了很多非常有价值的建议~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47db5408758, createdName=ms2000001912590380, createdTime=Fri Jun 04 13:12:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563308, encodeId=a889563308ff, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：两个审稿人，一个认为文章很好，小修，一个认为语言读不懂，还说懒得读下去，提了一些乱七八糟的问题，拒稿。编辑最终给了大修，现在我很惆怅啊，A revision will require extensive changes and possibly a significant reworking of the manuscript. Please note that we do not guarantee acceptance even after revision. 发篇文章真的伤筋动骨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sat Nov 17 16:59:00 CST 2018, time=2018-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184414, encodeId=fc561184414a8, content=这个杂志是所有的作者都是共一吗，每个作者都要确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3edd5463800, createdName=爱吃萝卜不吃青菜, createdTime=Fri Jan 14 23:03:48 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062690, encodeId=82f810626908a, content=快两个月了还是under review，，，，，是不是凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92645440603, createdName=mnr, createdTime=Thu Oct 21 20:27:07 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096899, encodeId=abc01096899bb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096900, encodeId=091b10969004d, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-12-22 ms7000000881357346 来自北京

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：外科;手术
经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗

56 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=970865, encodeId=01749e0865a0, content=审稿速度:3.0 经验分享：2021/02/23投稿，2021/05/07接受，一个月左右收到校样。同其他前辈分享的经验差不多，一审一个月左右，二审十几天。审稿人很认真负责，给了很多非常有价值的建议~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47db5408758, createdName=ms2000001912590380, createdTime=Fri Jun 04 13:12:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563308, encodeId=a889563308ff, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：两个审稿人，一个认为文章很好，小修，一个认为语言读不懂，还说懒得读下去，提了一些乱七八糟的问题，拒稿。编辑最终给了大修，现在我很惆怅啊，A revision will require extensive changes and possibly a significant reworking of the manuscript. Please note that we do not guarantee acceptance even after revision. 发篇文章真的伤筋动骨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sat Nov 17 16:59:00 CST 2018, time=2018-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184414, encodeId=fc561184414a8, content=这个杂志是所有的作者都是共一吗，每个作者都要确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3edd5463800, createdName=爱吃萝卜不吃青菜, createdTime=Fri Jan 14 23:03:48 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062690, encodeId=82f810626908a, content=快两个月了还是under review，，，，，是不是凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92645440603, createdName=mnr, createdTime=Thu Oct 21 20:27:07 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096899, encodeId=abc01096899bb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096900, encodeId=091b10969004d, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-09-15 Hello98 来自上海

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：外科学
经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。

38 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=970865, encodeId=01749e0865a0, content=审稿速度:3.0 经验分享：2021/02/23投稿，2021/05/07接受，一个月左右收到校样。同其他前辈分享的经验差不多，一审一个月左右，二审十几天。审稿人很认真负责，给了很多非常有价值的建议~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47db5408758, createdName=ms2000001912590380, createdTime=Fri Jun 04 13:12:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563308, encodeId=a889563308ff, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：两个审稿人，一个认为文章很好，小修，一个认为语言读不懂，还说懒得读下去，提了一些乱七八糟的问题，拒稿。编辑最终给了大修，现在我很惆怅啊，A revision will require extensive changes and possibly a significant reworking of the manuscript. Please note that we do not guarantee acceptance even after revision. 发篇文章真的伤筋动骨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sat Nov 17 16:59:00 CST 2018, time=2018-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184414, encodeId=fc561184414a8, content=这个杂志是所有的作者都是共一吗，每个作者都要确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3edd5463800, createdName=爱吃萝卜不吃青菜, createdTime=Fri Jan 14 23:03:48 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062690, encodeId=82f810626908a, content=快两个月了还是under review，，，，，是不是凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92645440603, createdName=mnr, createdTime=Thu Oct 21 20:27:07 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096899, encodeId=abc01096899bb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096900, encodeId=091b10969004d, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-07-19 190374007 来自江苏省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：感染
经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。

36 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=970865, encodeId=01749e0865a0, content=审稿速度:3.0 经验分享：2021/02/23投稿，2021/05/07接受，一个月左右收到校样。同其他前辈分享的经验差不多，一审一个月左右，二审十几天。审稿人很认真负责，给了很多非常有价值的建议~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47db5408758, createdName=ms2000001912590380, createdTime=Fri Jun 04 13:12:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563308, encodeId=a889563308ff, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：两个审稿人，一个认为文章很好，小修，一个认为语言读不懂，还说懒得读下去，提了一些乱七八糟的问题，拒稿。编辑最终给了大修，现在我很惆怅啊，A revision will require extensive changes and possibly a significant reworking of the manuscript. Please note that we do not guarantee acceptance even after revision. 发篇文章真的伤筋动骨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sat Nov 17 16:59:00 CST 2018, time=2018-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184414, encodeId=fc561184414a8, content=这个杂志是所有的作者都是共一吗，每个作者都要确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3edd5463800, createdName=爱吃萝卜不吃青菜, createdTime=Fri Jan 14 23:03:48 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062690, encodeId=82f810626908a, content=快两个月了还是under review，，，，，是不是凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92645440603, createdName=mnr, createdTime=Thu Oct 21 20:27:07 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096899, encodeId=abc01096899bb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096900, encodeId=091b10969004d, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-09-04 wawljwalj9232

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：外科;外科学
经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的

177 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=970865, encodeId=01749e0865a0, content=审稿速度:3.0 经验分享：2021/02/23投稿，2021/05/07接受，一个月左右收到校样。同其他前辈分享的经验差不多，一审一个月左右，二审十几天。审稿人很认真负责，给了很多非常有价值的建议~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47db5408758, createdName=ms2000001912590380, createdTime=Fri Jun 04 13:12:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563308, encodeId=a889563308ff, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：两个审稿人，一个认为文章很好，小修，一个认为语言读不懂，还说懒得读下去，提了一些乱七八糟的问题，拒稿。编辑最终给了大修，现在我很惆怅啊，A revision will require extensive changes and possibly a significant reworking of the manuscript. Please note that we do not guarantee acceptance even after revision. 发篇文章真的伤筋动骨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sat Nov 17 16:59:00 CST 2018, time=2018-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184414, encodeId=fc561184414a8, content=这个杂志是所有的作者都是共一吗，每个作者都要确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3edd5463800, createdName=爱吃萝卜不吃青菜, createdTime=Fri Jan 14 23:03:48 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062690, encodeId=82f810626908a, content=快两个月了还是under review，，，，，是不是凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92645440603, createdName=mnr, createdTime=Thu Oct 21 20:27:07 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096899, encodeId=abc01096899bb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096900, encodeId=091b10969004d, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2018-11-17 futuremaster

审稿速度:1.0 | 投稿命中率:5.0
经验分享：两个审稿人，一个认为文章很好，小修，一个认为语言读不懂，还说懒得读下去，提了一些乱七八糟的问题，拒稿。编辑最终给了大修，现在我很惆怅啊，A revision will require extensive changes and possibly a significant reworking of the manuscript. Please note that we do not guarantee acceptance even after revision. 发篇文章真的伤筋动骨。

220 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=970865, encodeId=01749e0865a0, content=审稿速度:3.0 经验分享：2021/02/23投稿，2021/05/07接受，一个月左右收到校样。同其他前辈分享的经验差不多，一审一个月左右，二审十几天。审稿人很认真负责，给了很多非常有价值的建议~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47db5408758, createdName=ms2000001912590380, createdTime=Fri Jun 04 13:12:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563308, encodeId=a889563308ff, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：两个审稿人，一个认为文章很好，小修，一个认为语言读不懂，还说懒得读下去，提了一些乱七八糟的问题，拒稿。编辑最终给了大修，现在我很惆怅啊，A revision will require extensive changes and possibly a significant reworking of the manuscript. Please note that we do not guarantee acceptance even after revision. 发篇文章真的伤筋动骨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sat Nov 17 16:59:00 CST 2018, time=2018-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184414, encodeId=fc561184414a8, content=这个杂志是所有的作者都是共一吗，每个作者都要确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3edd5463800, createdName=爱吃萝卜不吃青菜, createdTime=Fri Jan 14 23:03:48 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062690, encodeId=82f810626908a, content=快两个月了还是under review，，，，，是不是凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92645440603, createdName=mnr, createdTime=Thu Oct 21 20:27:07 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096899, encodeId=abc01096899bb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096900, encodeId=091b10969004d, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-01-14 爱吃萝卜不吃青菜

这个杂志是所有的作者都是共一吗，每个作者都要确认吗

40 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=970865, encodeId=01749e0865a0, content=审稿速度:3.0 经验分享：2021/02/23投稿，2021/05/07接受，一个月左右收到校样。同其他前辈分享的经验差不多，一审一个月左右，二审十几天。审稿人很认真负责，给了很多非常有价值的建议~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47db5408758, createdName=ms2000001912590380, createdTime=Fri Jun 04 13:12:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563308, encodeId=a889563308ff, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：两个审稿人，一个认为文章很好，小修，一个认为语言读不懂，还说懒得读下去，提了一些乱七八糟的问题，拒稿。编辑最终给了大修，现在我很惆怅啊，A revision will require extensive changes and possibly a significant reworking of the manuscript. Please note that we do not guarantee acceptance even after revision. 发篇文章真的伤筋动骨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sat Nov 17 16:59:00 CST 2018, time=2018-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184414, encodeId=fc561184414a8, content=这个杂志是所有的作者都是共一吗，每个作者都要确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3edd5463800, createdName=爱吃萝卜不吃青菜, createdTime=Fri Jan 14 23:03:48 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062690, encodeId=82f810626908a, content=快两个月了还是under review，，，，，是不是凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92645440603, createdName=mnr, createdTime=Thu Oct 21 20:27:07 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096899, encodeId=abc01096899bb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096900, encodeId=091b10969004d, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-10-21 mnr

快两个月了还是under review，，，，，是不是凉凉了

59 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=970865, encodeId=01749e0865a0, content=审稿速度:3.0 经验分享：2021/02/23投稿，2021/05/07接受，一个月左右收到校样。同其他前辈分享的经验差不多，一审一个月左右，二审十几天。审稿人很认真负责，给了很多非常有价值的建议~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47db5408758, createdName=ms2000001912590380, createdTime=Fri Jun 04 13:12:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563308, encodeId=a889563308ff, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：两个审稿人，一个认为文章很好，小修，一个认为语言读不懂，还说懒得读下去，提了一些乱七八糟的问题，拒稿。编辑最终给了大修，现在我很惆怅啊，A revision will require extensive changes and possibly a significant reworking of the manuscript. Please note that we do not guarantee acceptance even after revision. 发篇文章真的伤筋动骨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sat Nov 17 16:59:00 CST 2018, time=2018-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184414, encodeId=fc561184414a8, content=这个杂志是所有的作者都是共一吗，每个作者都要确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3edd5463800, createdName=爱吃萝卜不吃青菜, createdTime=Fri Jan 14 23:03:48 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062690, encodeId=82f810626908a, content=快两个月了还是under review，，，，，是不是凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92645440603, createdName=mnr, createdTime=Thu Oct 21 20:27:07 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096899, encodeId=abc01096899bb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096900, encodeId=091b10969004d, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-29 msSSSSSD

怎么撰写引言？区别于讨论？

75 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=970865, encodeId=01749e0865a0, content=审稿速度:3.0 经验分享：2021/02/23投稿，2021/05/07接受，一个月左右收到校样。同其他前辈分享的经验差不多，一审一个月左右，二审十几天。审稿人很认真负责，给了很多非常有价值的建议~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47db5408758, createdName=ms2000001912590380, createdTime=Fri Jun 04 13:12:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563308, encodeId=a889563308ff, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：两个审稿人，一个认为文章很好，小修，一个认为语言读不懂，还说懒得读下去，提了一些乱七八糟的问题，拒稿。编辑最终给了大修，现在我很惆怅啊，A revision will require extensive changes and possibly a significant reworking of the manuscript. Please note that we do not guarantee acceptance even after revision. 发篇文章真的伤筋动骨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sat Nov 17 16:59:00 CST 2018, time=2018-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184414, encodeId=fc561184414a8, content=这个杂志是所有的作者都是共一吗，每个作者都要确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3edd5463800, createdName=爱吃萝卜不吃青菜, createdTime=Fri Jan 14 23:03:48 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062690, encodeId=82f810626908a, content=快两个月了还是under review，，，，，是不是凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92645440603, createdName=mnr, createdTime=Thu Oct 21 20:27:07 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096899, encodeId=abc01096899bb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096900, encodeId=091b10969004d, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-28 Gym璨烨

引言和讨论如何写的不重复？

41 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务